| 70 |
60: Induction, Chitin degradation and resorption |
238: Induction, Pre-mature molting |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 868 |
850: Induction, CYP1A2/CYP1A5 |
844: Oxidation, Uroporphyrinogen |
Nov 29, 2016 |
May 31, 2018 |
1 AOP
|
| 3275 |
850: Induction, CYP1A2/CYP1A5 |
1392: Oxidative Stress |
Jul 4, 2024 |
Jul 4, 2024 |
1 AOP
|
| 1262 |
1206: Induction, Doublesex1 gene |
1209: Induction, Male reproductive tract |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 386 |
145: Induction, IKB inhibitory protein |
202: Inhibition, Nuclear factor kappa B (NF-kB) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 170 |
164: Induction, Liver “Dysfunctional” Changes by CGA 330050 |
147: Inhibition, Inducible Nitric Oxide Synthase by Metabolite CGA 265307 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1263 |
1209: Induction, Male reproductive tract |
1208: Increased, Male offspring |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 859 |
838: Induction, Microvesicular fat |
840: Formation, Liver fibrosis |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1518 |
1394: Sustained proliferation |
1395: Liver Cancer |
May 30, 2017 |
Oct 9, 2020 |
1 AOP
|
| 1059 |
1019: Induction, pharyngeal muscle paralysis |
1016: Inhibition, Feeding |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 261 |
238: Induction, Pre-mature molting |
328: Decrease, Fecundity |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 262 |
238: Induction, Pre-mature molting |
350: Increase, Mortality |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 263 |
238: Induction, Pre-mature molting |
351: Increased Mortality |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1050 |
1014: Induction, Somatic muscle paralysis |
351: Increased Mortality |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1055 |
1014: Induction, Somatic muscle paralysis |
1016: Inhibition, Feeding |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 3089 |
1014: Induction, Somatic muscle paralysis |
1015: Increased, Neuronal synaptic inhibition |
Oct 17, 2023 |
Oct 17, 2023 |
1 AOP
|
| 298 |
269: Induction, Sustained Cell Proliferation |
347: Formation, Liver tumor |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 299 |
270: Induction, Sustained Hepatotoxicity |
269: Induction, Sustained Cell Proliferation |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 2235 |
295: Induction, Upregulation of glucuronyltransferase activity |
401: Increase, Biliary excretion TH glucuronide |
Dec 9, 2020 |
Dec 9, 2020 |
None
|
| 2428 |
295: Induction, Upregulation of glucuronyltransferase activity |
1021: Increased, T4/T3 catabolism |
Jul 7, 2021 |
Jul 7, 2021 |
None
|
| 2478 |
295: Induction, Upregulation of glucuronyltransferase activity |
961: Increased, Clearance of thyroxine from serum |
Sep 10, 2021 |
Sep 10, 2021 |
3 AOPs
|
| 2483 |
295: Induction, Upregulation of glucuronyltransferase activity |
281: T4 in serum, Decreased |
Sep 14, 2021 |
Sep 14, 2021 |
None
|
| 2884 |
295: Induction, Upregulation of glucuronyltransferase activity |
2133: Increase, Glucuronidation of T4 |
Apr 12, 2023 |
Apr 12, 2023 |
None
|
| 916 |
901: Infiltration, Inflammatory cells |
902: Inflammation, Liver |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 3374 |
901: Infiltration, Inflammatory cells |
1198: Activation, Macrophages |
Oct 30, 2024 |
Oct 30, 2024 |
1 AOP
|